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Curable sexually transmitted infections (STIs) such as infection with Chlamydia trachomatis
(C. trachomatis), Neisseria gonorrhoeae (N. gonorrhoeae), and Trichomonas vaginalis (T.
vaginalis) can lead to adverse pregnancy and birth outcome. There are limited data on the
prevalence and correlate of STI in Ethiopia, yet pregnant women are not screened for cur-
able STI. Hence in this study, the prevalence of STIs and associated risk factors were
assessed.
Methodology
A cross- sectional study was conducted on consecutive women attending the delivery ward
at the Hawassa comprehensive and specialized hospital. Vaginal swabs collected at the
time of labor and delivery were tested for C. trachomatis, N. gonorrhoeae and T. vaginalis
using GeneXpert. Study participants responded to a questionnaire about their previous and
current obstetric history and socio-demographic characteristics. Possible independent fac-
tors for curable STIs were assessed by chi-square, bivariable, and multivariable, logistic
regression.
Results
Of the 350 vaginal swabs tested, 51 (14.6%, 95% CI: 10.9–18.3) were positive for one or
more curable STIs. The prevalence of C. trachomatis, N. gonorrhoeae and T. vaginalis were
8.3%, 4.3%, and 3.1%, respectively. STIs was associated (p<0.005) with the delivery out-
comes birth weight and gestational age. A 3-fold increase in odds of acquisition STIs was
found in currently unmarried women (AOR, 3.5; 95% CI: 1.1–10.4; p = 0.028), in women
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<25 years (AOR, 2.7; 95% CI 1.1–6.6; p = 0.031). Women reporting presence of vaginal dis-
charge (AOR, 7.7; 95% CI: 3.2–18.6; p < 0.001) and reporting pain during urination (AOR,
6.5; 95% CI: 2.6–16.2; p <0.001) found to associate with curable STIs.
Conclusion
The higher magnitude of STIs found in this population, and the absence of symptoms in
many illustrate the need for systematic follow-up during routine antenatal care primarily his-
tory taking and asking for signs and symptoms to provide early management and avoid long
term sequelae.
Introduction
Sexually transmitted infections (STIs) in pregnant women cause a significant global health
burden related to various adverse health outcomes especially among women in developing
countries [1]. Curable STIs consist of infections with Chlamydia trachomatis (C. trachomatis),
Neisseria gonorrhoeae (N. gonorrhoeae), and Trichomonas vaginalis (T. vaginalis) [2]. Major
complications of these infections include pelvic inflammatory disease, risk of ectopic preg-
nancy, spread to the foetus resulting in spontaneous abortion, preterm delivery, low birth
weight, and stillbirth [1, 3]. Besides this, STIs have enormous social and economic conse-
quences: marital conflict may occur when one of the partners develops STI or infertility [4].
Estimates of the prevalence and incidence of curable STIs remain high, with approximately
over one million new infections each day [5, 6]. According to the WHO’s 2016 estimate, the
prevalence of the four curable STIs among the reproductive age group of women is 3.8%,
0.9%, and 5.3% of C. trachomatis, N. gonorrhoea, and T. vaginalis respectively, while the Afri-
can region shared the highest prevalence [6].
The Ethiopian health policy follows the WHO recommendation, advocating the syndromic
management of curable STIs, encouraging pregnant women for regular surveillance and
screening for syphilis and HIV. However, despite known high global incidence, curable STIs
remain a neglected topic even in the area of research [7].
Since most STIs present asymptomatically, pregnant women, mainly in developing coun-
tries, rarely seek medical advice for this majority of them not diagnosed and treated [8]. For
better approach, studies recommended screening pregnant women using the syndromic
approach in the third trimester of pregnancy or before delivery as a solution to lessen bad out-
come [9]
On the other hand, studies reported that aetiological diagnosis of STI remains difficult due
to restricted access to laboratory diagnostics to guide appropriate treatment in developing
countries. And even if facilities are available, test results for people with suspected STIs take
days, making instant management of STI based on laboratory results impractical [10–12].
Because of these arguments, the WHO syndromic management has reached its limits and
needs to be updated by integrating laboratory tests to address asymptomatic STIs. Previous
studies also recommended the point-of-care tests (POCTs) that are accurate, rapid, simple and
affordable are urgently desirable in resource-constrained settings to support efficacious aetio-
logical diagnosis and treatment [13].
Therefore in this study, the prevalence of curable STIs and their association with delivery
outcomes were assessed using GeneXpert assay at Hawassa University Referral Hospital,
Ethiopia.
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Methods
Study setting and recruitment
Cross-sectional study was conducted among 350 consecutively enrolled pregnant women in
the obstetrics ward at Hawassa University comprehensive and specialized hospital (HU-CSH),
Ethiopia. From August to October 2020 consecutive pregnant women who came for delivery
at the obstetric ward were recruited for the study after written informed consent. The
HU-CSH is one of the teaching hospitals that serves as a referral centre for more than 5 million
inhabitants in the Southern Region of Ethiopia. The hospital has 500 beds, accommodating
around 2,504 pregnant women for antenatal care (ANC) visits and about 5,348 deliveries con-
ducted annually.
Sample size and technique
Sample size was estimated using a single population proportion formula with EPI-Info version
7. Considering the source population size greater than 50,000, the WHO prevalence estimate
of C.trachomatis 3.8% [6], level of confidence 95%, margin of error 2%, and response rate 90%,
sample size was calculated to be 349.
Data collection and testing
A midwife at the obstetric ward provided general information about the study to pregnant
women who came for delivery. Pregnant women agreeing to join in the study were interviewed
using a structured questionnaire translated in Amharic, the language spoken by most people
in the study area. The questionnaire was piloted on random mother at antenatal clinic to
ensure the validity and feasibility of the questions as conducted in similar studies. Information
related to socio-demographic characteristics (e.g., age, marital status, and educational level),
obstetric history, and behavioral data were collected. The midwife-nurse took a vaginal swab
specimen using Xpert CT/NG Vaginal/Endocervical specimen collection kits (Cepheid, Sun-
nyvale, California, USA). Swabs inserted in to the vaginal opening about 2 inches and gently
turning around, ensuring rubbing the swab against the vaginal wall.
The collected samples were transported to the microbiology laboratory within 12 hours of
collection. The trained microbiologists tested the specimen as per the manufacturer’s instruc-
tion (Xpert CT/NG and Xpert TV assays, Cepheid, Sunnyvale, California, USA). The Xpert
assays have greater than 99% sensitivity and specificity for the organisms tested [14, 15]. The
turnaround time for results was 60 minutes for T. vaginalis and 90 minutes for C. trachomatis/
N. gonorrhoeae.
Ethical considerations
The ethics review committee of Hawassa University (CMHS/283/2012), Jimma University
(IHRPGD/458/2020), National Health Research Ethics Review Committee (SRA/14.1/
144483/2020) Ethiopia, and Ghent University (PA2019-038/BC-08458) Belgium, approved the
study. All participants provided written, informed consent for study participation. Women
who had curable STIs were linked to their physician and treated according to the national
guideline [16]. Likewise, womens partner were referred for testing and treatment for STIs.
Data analysis
Descriptive statistics were used to characterize the socio-demographic and obstetric and medi-
cal characteristics of the participants. We evaluated the prevalence of STI and factors associ-
ated using a logistic regression model after adjusted for a priori variables including mother’s
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age, educational level, marital statues and occupation. Finally, multivariable logistic regression
was used to identify characteristics independently associated with having an STI and adjusting
to other factors. Variables with a significant level of<0.2 were included in the final model. Sta-
tistical significance of variables in the final model was assessed at the 0.05 level. SPSS software
version 20.0 (SPSS Inc. Chicago, IL, USA) was used for all analyses.
Results
A total of 350 pregnant women were recruited and tested for curable STIs in this study. Partici-
pants’ mean age was 26.8, ranging from 17–41 years old and about 44% under 25 years. The
majority (87.4%) of women were married, residing in an urban setting (79.1%), and Christian
protestant (53%). Educationally more than half of the participants (63%) were above or at sec-
ondary level education (Table 1).
The majority of women (60.9%) gave birth through spontaneous vaginal delivery (SVD) and
women who underwent caesarean section were 26.9%. Male to female ratio of newborn looked
proportional, 47.4% male to 52.6% female. Three-fourths of participants had a previous preg-
nancy, and 95.1% had ANC follow up during their pregnancy. The majority of birth were alive
(97.7%), and there were 6 (1.7%) stillbirth and 2 (0.6%) early neonatal death. About 79.7% of
birth weight range between 2500–4000 gram and 15.5% of pregnant women gave preterm birth.
Pregnant women STIs was associated (p<0.005) with delivery outcome of birth weight and gesta-
tional age. But has no with previous history of preterm birth and history of STIs (Tables 1 and 2).
Prevalence of curable STIs
STIs were detected in 14.6% (51/350) (95% CI: 10.9–18.3) of the 350 women. The prevalence
was 8.3% (29/350) (95% CI: 5.1–11.1) for C. trachomatis, 4.3% (15/350) (95% CI: 2.3–6.9) for
N. gonorrhoeae, and 3.1% (11/350) (95% CI: 1.4–4.9) for T. vaginalis (Table 3). Four pregnant
women had a co-infection. From these; 3 women were positive for N. gonorrhoeae and C. tra-
chomatis and one women for C. trachomatis and T. vaginalis.
Pregnant women’s age, vaginal discharge, gestational age and birthweight had significant
association (p<0.05) with N. gonorrhoeae positivity. Likewise, symptom of STIs (vaginal dis-
charge and pain during urination) and birthweight had association with C. trachomatis and T.
vaginalis positivity (Table 3).
STIs and associated factors
In a bivariable analysis after adjusted for a priori variables, STIs were more common among
women who were currently unmarried, less than 25 years women, who give a preterm and lea-
ser birth weight baby, women with lower educational status, women with symptom of vaginal
discharge and pain during urination, and who had more than one sexual partner (Table 4).
Multivariable logistic regression analysis indicates, younger women (<25 years) were at
higher risk of having curable STI compared to elders (AOR, 2.7; 95% CI 1.1–6.6; p = 0.031). The
other independent predictors associated with curable STIs were unmarried women (AOR, 3.4;
95% CI: 1.1–10.4; p = 0.028) compared to married women, self-employed women compared to
un-employed (AOR, 7.6; 95%CI: 1.7–34.7; p = 0.009), underweight (AOR, 5.9; 95% CI: 1.8–
19.1; p< 0.003) compared to normal birth weight, women reporting presence of vaginal dis-
charge (AOR, 8.3; 95% CI: 3.4–20.5; p< 0.001) compared to no vaginal discharge (Table 4).
Women reporting pain during urination were six-fold infected by at least one curable STI
than those with no pain (AOR, 6.5; 95% CI: 2.6–16.2; p<0.001) (Table 4). Having more than
one sexual partner and an educational level of only junior or primary were identified as poten-
tial predictors of curable STIs in the bivariable analysis but not multivariable analysis.
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Discussion
Among pregnant women who attended delivery at the Hawassa comprehensive and special-
ized hospital, 14.6% tested positive at least for one of the three curable STIs: C. trachomatis
8.3%, N. gonorrhoeae 8.3%, and T. vaginalis 3.1%. A statistically significant association was
observed between STIs and variables like age (<25 years), being unmarried, having lower or
primary education, having vaginal discharge, and pain during urination.
Table 1. Socio-demographic, obstetric history and behavioural characteristics of the 350 pregnant women and those with STI (n = 51).
Characteristics Total (N = 350) n (%) STI-Positive (n = 51) n (%) p-value
Age of mothers
<25 153 (43.7) 36 (23.5) < 0.001
>25 197 (56.3) 15 (7.6)
Marital status
Unmarried 44(12.6) 15 (34.1) 0.020
Married 306 (87.4) 36 (11.8)
Residence
Urban 277(79.1) 41 (14.8) 0.812
Rural 73 (20.9) 10 (13.7)
Occupation
Self employed 82(23.4) 21 (25.6) 0.006
Government worker 107(30.6) 17 (15.9)
Non-government worker 47(13.4) 3 (6.4)
Student 46(13.1) 5 (10.9)
Not employed 68(19.4) 5 (7.4)
Religion
Orthodox 76(21.7) 15 (19.7) 0.124
Protestant 187(53.4) 27 (14.4)
Muslim 67(19.1) 7 (10.4)
Catholic 11(3.1) 1 (9.1)
Others 9(2.6) 1 (11.1)
level of Education
Primary and below 127(36.3) 27 (21.3) 0.008
Secondary and above 223 (63.7) 24 (10.8)
Gravidity
Primigravida 88(25.1) 11 (12.5) 0.525
Multigravida 262 (74.9) 40 (15.3)
ANC follow up
Yes 333(95.1) 50 (15) 0.319
No 17 (4.9) 1 (5.9)
History of preterm birth
Yes 22(6.3) 3 (13.6) 0.898
No 328 (93.7) 48 (14.6)
Previous history STIs
Yes 17(4.9) 4 (13.5) 0.290
No 333 (95.1) 47 (14.1)
Number of lifetime sexual partner
One 295 (84.3) 30 (10.2) < 0.033
More than one 55(15.7) 21 (38.2)
STIs, sexually transmitted infections; ANC, Antenatal care.
https://doi.org/10.1371/journal.pone.0248958.t001
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Table 2. Curable sexually transmitted infection in relation to symptom and Birth outcome of pregnant women attending obstetric ward at Hawassa comprehensive
and specialized hospital.
Characteristics Total (N = 350) n (%) STI-Positive (n = 51) n (%) P-value
Sex of newborn
Male 166 (47.4) 25 (15.1) 0.806
Female 184 (52.6) 26 (14.1)
Birth weight
<2500gram 33 (9.4) 13 (39.4) < 0.001
�2500 gram 317 (90.6) 38 (12.0)
Gestational age
Preterm 53(15.1) 18 (34) < 0.001
Term 297 (84.9) 33 (11.1)
Birth outcome
Alive 342 (97.7) 49 (14.3)
Stillbirth 6 (1.7) 2 (33.3) 0.213
Early neonatal death 2 (0.6) 0 (0)
Mode of delivery
SVD 213(60.9) 31 (14.6) 0.334
CS 94(26.9) 12 (12.8) 0.263
Episiotomy 31(8.9) 5 (16.1) 0.506
Forceps/vacuume extraction 12(3.4) 3 (25)
Vaginal discharge
Yes 59(16.9) 33 (55.9) < 0.001
No 291 (83.1) 18 (6.2)
Pain during urination
Yes 57(16.3) 29 (50.9) < 0.001
No 293 (83.7) 22 (7.5)
SVD, Spontaneous vaginal delivery; CS, Caesarean section.
https://doi.org/10.1371/journal.pone.0248958.t002
Table 3. Pregnancy outcome and symptoms of sexually transmitted infections by laboratory confirmed STIs of study participant.
variables N. gonorrhoeae n = 15 P-value C. trachomatis n = 29 P-value T. vaginalis n = 11 P-value
Age
<25 11/153 (7.2) 0.018 21/153 (13.7) 0.001 8/153 (5.2) 0.064
>25 4/197 (2.0) 8/197 (4.1) 3/197 (1.5)
Gestational age
Term 9/297 (3.0) 0.015 21/297 (7.1) 0.060 6/297 (2.0) 0.015
Preterm 6/53 (11.3) 8/53 (8.3) 5/53 (9.4)
Birth weight
<2.5 Kg 6/33 (18.2) 0.001 6/33 (18.2) 0.043 4/33 (12.1) 0.014
>2.5 Kg 9/317 (2.8) 23/317 (7.3) 7/317 (2.2)
Vaginal discharge
Yes 9/59 (15.3) <0.001 19/59 (32.2) <0.001 8/59 (13.6) <0.001
No 6/291 (2.1) 10/291 (3.4) 3/291 (1.0)
Pain during urination
Yes 5/57 (8.8) 0.078 20/57 (35.1) <0.001 6/57 (10.5) 0.003
No 10/293 (3.4) 9/293 (3.1) 5/293 (1.7)
Prevalence (%) 15/350 (4.3) 29/350 (8.3) 11/350 (3.1)
https://doi.org/10.1371/journal.pone.0248958.t003
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The prevalence of C. trachomatis in the present study is within the range and somehow
comparable (0–31.1%, with a pooled prevalence of 6.9%) to a systematic review in sub-Saharan
Africa compiled by Kristina Adachi et al.; [17]. Another systematic review of low and middle-
income countries revealed a mean prevalence of 4.2% of C. trachomatis in east Africa, which is
lower than our results [7]. Results comparable to our finding for C. trachomatis were reported
in a systematic review with a pooled prevalence of 7.8% in Sub-Saharan Africa among repro-
ductive-age women [18]; 8% in Botswana [19], and 9.8% in central Ethiopia [20]. On the other
hand, our findings were substantially lower compared to previous findings: 18.9% in the same
area (Hawassa) [21] using rapid antigen test kit, 14.9% in Kenya [22], 20% in South Africa [23]
and 26.5% among HIV positive pregnant women in South Africa [24]. In this study women’s
age, vaginal discharge, and birthweight had significant association with C. trachomatis
positivity.
Table 4. Bivariable and multivariable analysis of socio-demographic characteristics of pregnant women with curable sexually transmitted infections attending
obstetric ward at Hawassa comprehensive and specialized hospital.
Characteristics Curable STI Number (%) Bivariate analysis Multivariate analysis
COR P-value AOR P-value
Age
<25 36(23.5) 3.7(1.9–7.1) < 0.001 2.7(1.1–6.6) 0.031
>25 15 (7.6) 1 1
Marital statues
Married 36(11.8) 1 1
Unmarried 15(34.1) 3.9 (1.9–7.9) 0.020 3.4(1.1–10.4) 0.028
Occupation
Self employed 21(41.2) 4.3(1.5–12.2) 0.006 7.6(1.7–34.2) 0.009
Government worker 17(15.9) 2.3(0.8–6.7) 0.105 3.7(0.9–15.8) 0.078
Non-government worker 3(6.4) 0.9(0.2–3.8) 0.841 2.3(0.4–15.4) 0.391
Student 5(10.9) 1.5 (0.4–5.6) 0.517 1.3(0.2–7.5) 0.795
Not employed 5 (7.4) 1 1
Education
Primary and below 27(21.3) 2.3(1.2–4.4) 0.017 2.3(0.9–5.4) 0.067
Secondary and above 223(63.7) 1 1
Gestational age
Term 33 (11.1) 1 1 �
Preterm 18(34) 3.7 (1.7–7.9) 0.001 2.4(0.9–6.8) 0.088
Birth weight
<2500gram 13 (39.4) 6.8(2.7–16.9) <0.001 5.9(1.8–19.1) 0.003
�2500 gram 38 (12.0) 1 1 �
Vaginal discharge
Yes 33(55.9) 14.4(6.8–30.8) < 0.001 7.7(3.2–18.6) < 0.001
No 18(6.2) 1 1 �
Pain during urination
Yes 29(50.9) 11.4(5.3–24.7) < 0.001 6.5(2.6–16.2) < 0.001
No 22(7.5) 1 1 �
Number of lifetime sexual partners
One 30(10.2) 1 1 �
More than one 21(38.2) 5.9 (2.7–12.8) < 0.001 2.9(1.0–8.3) 0.048
� Model adjusted for maternal age, marital status, occupation and educational level.
STIs, sexually transmitted infections.
https://doi.org/10.1371/journal.pone.0248958.t004
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The rate of T. vaginalis in this study was lower than findings from previous studies; 4.98%
in Jimma, Ethiopia [25] using culture system, 5.3% in central Ethiopia [20] using rapid test
kits, 7.4% in Kenya [22] using GeneXpert, 9.1% in Nigeria [26] using microscopic method,
15% in South Africa [23] and 16.7% among HIV positive pregnant women in South Africa
[24]. This might be due difference in laboratory assays used besides socio-demographic varia-
tion in of study population. Our study presented significant differences in gestational age,
birth weight and symptom of STIs (vaginal discharge and pain during urination) among preg-
nant women with and without T. vaginalis.
Similarly, the prevalence of N. gonorrhoea in the present study was slightly lower than previ-
ously published results in the same study area, 5.1% [27] done using culture techniques but
comparable with the study (4.3%) in central Ethiopia [20] using rapid test kits. However, our
result was higher than the report from another study’s report in Hawassa (0.31%) [21] using
rapid antigen test kit. Again the possible reasons might be due to different laboratory proce-
dures applied. Also our study showed that maternal N. gonorrhoea positivity had significant
association with gestational age, birthweight and mother’s age groups. Previous studies also
has reported that birthweight and gestational age at birth has significant association with
maternal N. gonorrhoea infection [1].
Age was found to be a significantly associated factor with STIs. Young age (<25 years) had
a three-fold increased risk for curable STIs, which is in line with previous similar findings [21,
27]. It has been speculated that more sexually active behaviour is seen among youngsters com-
pared to their elders. Other studies also reported a younger maternal age as a risk factor for
STIs [28]. Hence as indicated by Centre for disease control and prevention (CDC) of America,
at the first prenatal visit screening all pregnant women (mainly younger women <25 years) for
curable STIs is mandatory. The fact that most curable STIs are silent or asymptomatic if young
women get infected, they might not distinguish the sign of pregnancy from STI sourced vagi-
nal discharge and pain during urination due to lack of experience [29]
Pregnant women with curable STIs had a 4-fold increase odds of giving preterm birth. This
finding was in agreement with studies, which revealed STIs have been implicated in adverse
pregnancy outcomes including preterm delivery and low birth weight [30, 31]. Likewise,
women with curable STIs were at higher odds of giving low birth weight even though were not
included in the final models. Both preterm birth and low birth weight are leading factors of
neonate morbidity and mortality, particularly in developing countries where neonatal inten-
sive care facilities are not often available [12, 30, 32].
In this study number of sexual partners of women found to be associated with STIs. Also
symptoms such as vaginal discharge and pain during urination were significantly associated
with STI. This association has similarities with study reports from Ethiopia [25, 33]. Although
maternal healthcare service utilization is an important predictor of favourable maternal and
child health outcomes, in Ethiopia only a few health centres offer STI diagnosis. Therefore the
Ethiopian ANC follow-up policy should focus on addressing the possible strategies in STI pre-
vention among pregnant women during their ANC visit to visualised healthy alive birth. In
addition to compelling evidence that demands the development and validation of point-of-
care tests for STIs [9].
Compared to the pooled stillbirth rate of Ethiopia (3.7%) and early neonatal death of
(2.9%), compiled through systematic review, our result shows some reduction, 6 (1.7%) still-
birth and 2 (0.6%) early neonatal death [34]. On the other hand, although 15.5% of pregnant
women gave pre-term birth, it lacks any association with women STIs. Similarly, association
was not observed with the mode of delivery, ANC follow-up and gravidity of women, however,
literature showed the association of STIs with these predictors [33, 35].
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As to the World Health Organization, pregnant women should visit antenatal care at least
four times during pregnancy aimed to risk identifications, prevention and management of
pregnancy related diseases, and health education and health promotion [36]. However, as syn-
dromic approach offers treatment for a group of diseases the lack of standard of antenatal care
and overlooking curable STIs in Ethiopia has significant consequence for developing fetus
beyond. In this study even though the symptom of STIs has an association with STIs positivity,
STIs were detected in symptomless women too. This implicates that syndromic management
can miss and left untreated some of the women that rises adverse consequences. Also it has
been reported in previous study in central Ethiopia that the higher rate of maternal STIs and
its impact on the unborn child demonstrate the need for screening and treatment programmes
in order to prevent sequel [20]. Therefore, such type of findings demand serious attention in
order strengthening the existing ANC services through integration of diagnostic for curable
STIs rather than exclusively depend on the syndromic management.
As the study was a facility-based, it could not show the overall picture of STIs in the source
population where ANC follow-up is not an optimum level. Besides, we could not verify the
time when the women got infected as it was a cross-sectional study. Subsequent effects on
babies delivered from those STIs positive women were not studied. Meanwhile, the wider con-
fidence interval of the effect measures for some variables implies the need to consider a larger
sample size in future studies of the same.
Conclusion
The high prevalence of STIs in the study area continue to have an impact on pregnancy out-
come. The absence of symptoms in many illustrates the need for systematic follow-up during
routine antenatal care primarily history taking and asking for signs and symptoms of an STI.
In the meantime, the syndromic approach needs to be updated by integrating antenatal screen-
ing services for curable STIs through the provision of affordable, rapid, point-of-care screening
tests in resource-constrained antenatal care settings.
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